Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en
- PMID: 8553569
- DOI: 10.1006/viro.1995.0078
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en
Abstract
We report the selection and characterization of influenza A/NWS-G70c and B/HK/8/73 (HG) viruses which are resistant to the potent influenza neuraminidase inhibitor, 4-guanidino-Neu5Ac2en. Viruses were selected which replicated in MDCK cells in the presence of 20 micrograms/ml inhibitor. The neuraminidase of resistant viruses was > 200-fold more resistant to 4-guanidino-Neu5Ac2en than was the neuraminidase of the parent viruses. Although amounts of neuraminidase protein were similar in resistant and parent viruses, the enzyme activity of the resistant neuraminidase heads was reduced by > 95% for the substrates used. Relative to parent viruses, the resistant viruses replicated to equal or greater titers in tissue culture and in embryonated chicken eggs. Sequence analysis revealed a single nucleotide mutation in the neuraminidase gene of each virus resulting in the change of the conserved Glu 119 (which lies in a pocket beneath the active site of the enzyme) to Gly thus eliminating an electrostatic interaction with the C-4 guanidinium moiety of the inhibitor. Mutations (Asn-->Ser) at amino acids 145 and 150 were also found in the hemagglutinin gene of the B/HK/8/73 (HG) virus resistant to 4-guanidino-Neu5Ac2en. No changes were found in the hemagglutinin gene of the resistant A/NWS-G70c virus.
Similar articles
-
Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.Virology. 1995 Dec 20;214(2):475-84. doi: 10.1006/viro.1995.0058. Virology. 1995. PMID: 8553549
-
Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.Virology. 1997 Nov 24;238(2):265-72. doi: 10.1006/viro.1997.8810. Virology. 1997. PMID: 9400599
-
Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture.J Infect Dis. 1997 Aug;176 Suppl 1:S66-8. doi: 10.1086/514179. J Infect Dis. 1997. PMID: 9240698
-
Zanamivir. A potent and selective inhibitor of influenza A and B viruses.Clin Pharmacokinet. 1999;36 Suppl 1:v-ix. Clin Pharmacokinet. 1999. PMID: 10429834 Review. No abstract available.
-
Zanamivir: from drug design to the clinic.Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1885-93. doi: 10.1098/rstb.2001.1021. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11779388 Free PMC article. Review.
Cited by
-
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.J Virol. 2010 Sep;84(18):9427-38. doi: 10.1128/JVI.00373-10. Epub 2010 Jul 14. J Virol. 2010. PMID: 20631138 Free PMC article.
-
Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.J Virol. 2015 Apr;89(8):4575-87. doi: 10.1128/JVI.02473-14. Epub 2015 Feb 11. J Virol. 2015. PMID: 25673705 Free PMC article.
-
Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient.Open Forum Infect Dis. 2019 Nov 18;6(12):ofz493. doi: 10.1093/ofid/ofz493. eCollection 2019 Dec. Open Forum Infect Dis. 2019. PMID: 32128335 Free PMC article.
-
Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.J Virol. 1998 Mar;72(3):2456-62. doi: 10.1128/JVI.72.3.2456-2462.1998. J Virol. 1998. PMID: 9499107 Free PMC article.
-
Zanamivir: an update of its use in influenza.Drugs. 2002;62(1):71-106. doi: 10.2165/00003495-200262010-00004. Drugs. 2002. PMID: 11790157 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous